Skip to main content
Fig. 6 | Chinese Medicine

Fig. 6

From: A network pharmacology approach to reveal the pharmacological targets and biological mechanism of compound kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validation

Fig. 6

The HPLC–MS of CKI and standard substances. The red and the blue represents CKI and standard substances respectively. 10 compounds were identified by HPLC–MS, including oxysophocarpine, matrine, sophocarpine, sophoridine, oxynamatrine, N-methylcytisine, sophoranol, liriodendrin, trifolirhizin and macrozamin

Back to article page